Gespeichert in:
Titel: | Plant-Based Therapeutics, Volume 2 The Brassicaceae Family / |
---|---|
Von: |
by Ivan A. Ross.
|
Person: |
Ross, Ivan A.
author. aut http://id.loc.gov/vocabulary/relators/aut |
Hauptverfasser: | |
Körperschaft: | |
Format: | Elektronisch E-Book |
Sprache: | Englisch |
Veröffentlicht: |
Cham :
Springer Nature Switzerland : Imprint: Springer,
2024.
|
Ausgabe: | 1st ed. 2024. |
Schlagwörter: | |
Medienzugang: | https://doi.org/10.1007/978-3-031-63681-3 |
Zusammenfassung: | For centuries, research has been conducted on the therapeutics of Brassicaceae plants and their health-promoting effects. Cato the Elder (234-149 BCE) documented their properties in his work De agri cultura and recommended using cabbage to compress wounds, swelling, burns, and bone dislocations. For arthritis, he recommended chopped raw cabbage mixed with coriander and cured cabbage mixed with vinegar and honey. In a groundbreaking discovery in the 1990s, scientists at Johns Hopkins University isolated sulforaphane from broccoli, revealing its potent anticancer properties. This naturally occurring compound has proven highly effective, safe, and tolerable and holds immense promise as a chemoprevention agent. It has the potential to combat various cancers, including breast, prostate, gastrointestinal, melanoma, lung, brain, and bladder. But its potential does not stop there. It also shows promise in treating cardiovascular and neurodegenerative diseases and diabetes, offering hope for those affected. The cancer-protecting properties of Brassica plants are mediated through compounds that induce a variety of physiological processes, including antioxidant action, detoxifying enzymes, inducing apoptosis, and cell cycle regulation. Glucosinolate breakdown products can affect several stages of cancer development, including the inhibition of activation enzymes (phase I) and the induction of detoxification enzymes (phase II). Isothiocyanates and indole products formed from glucosinolates regulate cancer cell development by regulating target enzymes, controlling apoptosis, inhibiting angiogenesis, metastasis, and the migration of cancer cells, and blocking the cell cycle. Sulforaphane, found in abundance in broccoli sprouts, plays a crucial role in upregulating the transcriptional activity of specific genes and restoring epigenetic alterations. This is particularly significant as it modifies epigenetic pathways by targeting histone deacetylases and DNA methyltransferases. These modifications, in turn, alter gene transcription and expression, particularly in the case of cancers. This intricate process of gene regulation is a fascinating study area, making broccoli sprouts a compelling component of the 'epigenetic diet.' Sulforaphane induces the cytoprotective enzyme NQO1. The inducible expression of NQO1 is regulated principally through the Keap1-Nrf2-ARE signaling pathway. The activation of the Nrf2-Keap1 signaling pathway heralds the beneficial actions of drugs known to affect Nrf2 signaling, such as dimethyl fumarate, an FDA-approved treatment for multiple sclerosis, and bardoxolone methyl for chronic kidney disease. There is optimism that the overall strategies are moving forward. Sulforaphane-rich broccoli sprout extracts provide one avenue toward this end. |
Umfang: | 1 Online-Ressource (XXIII, 820 p.) |
ISBN: | 9783031636813 |
Internformat
MARC
LEADER | 00000nam a22000005i 4500 | ||
---|---|---|---|
001 | ZDB-2-SBL-978-3-031-63681-3 | ||
003 | DE-He213 | ||
005 | 20241019125728.0 | ||
007 | cr nn 008mamaa | ||
008 | 241019s2024 sz | o |||| 0|eng d | ||
020 | |a 9783031636813 |9 978-3-031-63681-3 | ||
024 | 7 | |a 10.1007/978-3-031-63681-3 |2 doi | |
050 | 4 | |a QK | |
072 | 7 | |a PST |2 bicssc | |
072 | 7 | |a SCI011000 |2 bisacsh | |
072 | 7 | |a PST |2 thema | |
082 | 7 | |a 580 |2 23 | |
100 | 1 | |a Ross, Ivan A. |e author. |4 aut |4 http://id.loc.gov/vocabulary/relators/aut | |
245 | 1 | 0 | |a Plant-Based Therapeutics, Volume 2 |h [electronic resource] : |b The Brassicaceae Family / |c by Ivan A. Ross. |
250 | |a 1st ed. 2024. | ||
264 | 1 | |a Cham : |b Springer Nature Switzerland : |b Imprint: Springer, |c 2024. | |
300 | |a 1 Online-Ressource (XXIII, 820 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
347 | |a text file |b PDF |2 rda | ||
505 | 0 | |a Ch01: The History of Brassicaceae Plants -- Ch-02: The Bioactive Components of Brassicaceae -- Ch-03: Chemical Constituents of Brassicaceae -- Ch-04: Nutrigenomics and Metabolomics of the Bioactive Compounds -- ch-05: The Anticarcinogenic Properties of Brassica Vegetables -- ch-06: Neurodegenerative Diseases -- ch-07: Epigenetic Modulation by Isothiocyanates -- ch-08: Breast Cancer -- ch-09: Brain Cancer -- ch-10: Cancer of the Gastrointestinal Tract -- ch-11: Cancer of the Urinary Bladder -- ch-12: Prostate Cancer -- Ch13: Brassica Vegetables and Hypothyroidism -- ch14: Brassicaceae and Viral Diseases -- ch15:Melatonin in Plants and Animals. | |
520 | |a For centuries, research has been conducted on the therapeutics of Brassicaceae plants and their health-promoting effects. Cato the Elder (234-149 BCE) documented their properties in his work De agri cultura and recommended using cabbage to compress wounds, swelling, burns, and bone dislocations. For arthritis, he recommended chopped raw cabbage mixed with coriander and cured cabbage mixed with vinegar and honey. In a groundbreaking discovery in the 1990s, scientists at Johns Hopkins University isolated sulforaphane from broccoli, revealing its potent anticancer properties. This naturally occurring compound has proven highly effective, safe, and tolerable and holds immense promise as a chemoprevention agent. It has the potential to combat various cancers, including breast, prostate, gastrointestinal, melanoma, lung, brain, and bladder. But its potential does not stop there. It also shows promise in treating cardiovascular and neurodegenerative diseases and diabetes, offering hope for those affected. The cancer-protecting properties of Brassica plants are mediated through compounds that induce a variety of physiological processes, including antioxidant action, detoxifying enzymes, inducing apoptosis, and cell cycle regulation. Glucosinolate breakdown products can affect several stages of cancer development, including the inhibition of activation enzymes (phase I) and the induction of detoxification enzymes (phase II). Isothiocyanates and indole products formed from glucosinolates regulate cancer cell development by regulating target enzymes, controlling apoptosis, inhibiting angiogenesis, metastasis, and the migration of cancer cells, and blocking the cell cycle. Sulforaphane, found in abundance in broccoli sprouts, plays a crucial role in upregulating the transcriptional activity of specific genes and restoring epigenetic alterations. This is particularly significant as it modifies epigenetic pathways by targeting histone deacetylases and DNA methyltransferases. These modifications, in turn, alter gene transcription and expression, particularly in the case of cancers. This intricate process of gene regulation is a fascinating study area, making broccoli sprouts a compelling component of the 'epigenetic diet.' Sulforaphane induces the cytoprotective enzyme NQO1. The inducible expression of NQO1 is regulated principally through the Keap1-Nrf2-ARE signaling pathway. The activation of the Nrf2-Keap1 signaling pathway heralds the beneficial actions of drugs known to affect Nrf2 signaling, such as dimethyl fumarate, an FDA-approved treatment for multiple sclerosis, and bardoxolone methyl for chronic kidney disease. There is optimism that the overall strategies are moving forward. Sulforaphane-rich broccoli sprout extracts provide one avenue toward this end. | ||
650 | 0 | |a Botany. | |
650 | 0 | |a Alternative medicine. | |
650 | 0 | |a Pharmacology. | |
650 | 0 | |a Medicinal chemistry. | |
650 | 0 | |a Agriculture. | |
650 | 0 | |a Physiology. | |
650 | 1 | 4 | |a Plant Science. |
650 | 2 | 4 | |a Complementary and Alternative Medicine. |
650 | 2 | 4 | |a Pharmacology. |
650 | 2 | 4 | |a Medicinal Chemistry. |
650 | 2 | 4 | |a Agriculture. |
650 | 2 | 4 | |a Physiology. |
710 | 2 | |a SpringerLink (Online service) | |
773 | 0 | |t Springer Nature eBook | |
776 | 0 | 8 | |i Printed edition: |z 9783031636806 |
776 | 0 | 8 | |i Printed edition: |z 9783031636820 |
776 | 0 | 8 | |i Printed edition: |z 9783031636837 |
966 | 4 | 0 | |l DE-355 |p ZDB-2-SBL |q UBG_PDA_SBL |u https://doi.org/10.1007/978-3-031-63681-3 |3 Volltext |
912 | |a ZDB-2-SBL | ||
912 | |a ZDB-2-SXB | ||
950 | |a Biomedical and Life Sciences (SpringerNature-11642) | ||
950 | |a Biomedical and Life Sciences (R0) (SpringerNature-43708) | ||
912 | |a ZDB-2-SBL | ||
049 | |a DE-355 |
Datensatz im Suchindex
DE-BY-UBR_katkey | ZDB-2-SBL-978-3-031-63681-3 |
---|---|
_version_ | 1835726566896697344 |
adam_text | |
any_adam_object | |
author | Ross, Ivan A. |
author_corporate | SpringerLink (Online service) |
author_corporate_role | |
author_facet | Ross, Ivan A. SpringerLink (Online service) |
author_role | aut |
author_sort | Ross, Ivan A. |
author_variant | i a r ia iar |
building | Verbundindex |
bvnumber | localUBR |
callnumber-first | Q - Science |
callnumber-label | QK |
callnumber-raw | QK |
callnumber-search | QK |
callnumber-sort | QK |
callnumber-subject | QK - Botany |
collection | ZDB-2-SBL ZDB-2-SXB |
contents | Ch01: The History of Brassicaceae Plants -- Ch-02: The Bioactive Components of Brassicaceae -- Ch-03: Chemical Constituents of Brassicaceae -- Ch-04: Nutrigenomics and Metabolomics of the Bioactive Compounds -- ch-05: The Anticarcinogenic Properties of Brassica Vegetables -- ch-06: Neurodegenerative Diseases -- ch-07: Epigenetic Modulation by Isothiocyanates -- ch-08: Breast Cancer -- ch-09: Brain Cancer -- ch-10: Cancer of the Gastrointestinal Tract -- ch-11: Cancer of the Urinary Bladder -- ch-12: Prostate Cancer -- Ch13: Brassica Vegetables and Hypothyroidism -- ch14: Brassicaceae and Viral Diseases -- ch15:Melatonin in Plants and Animals. |
dewey-full | 580 |
dewey-hundreds | 500 - Natural sciences and mathematics |
dewey-ones | 580 - Plants |
dewey-raw | 580 |
dewey-search | 580 |
dewey-sort | 3580 |
dewey-tens | 580 - Plants |
discipline | Biologie |
edition | 1st ed. 2024. |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05306nam a22005655i 4500</leader><controlfield tag="001">ZDB-2-SBL-978-3-031-63681-3</controlfield><controlfield tag="003">DE-He213</controlfield><controlfield tag="005">20241019125728.0</controlfield><controlfield tag="007">cr nn 008mamaa</controlfield><controlfield tag="008">241019s2024 sz | o |||| 0|eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783031636813</subfield><subfield code="9">978-3-031-63681-3</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-3-031-63681-3</subfield><subfield code="2">doi</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">QK</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">PST</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">SCI011000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">PST</subfield><subfield code="2">thema</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">580</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Ross, Ivan A.</subfield><subfield code="e">author.</subfield><subfield code="4">aut</subfield><subfield code="4">http://id.loc.gov/vocabulary/relators/aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Plant-Based Therapeutics, Volume 2</subfield><subfield code="h">[electronic resource] :</subfield><subfield code="b">The Brassicaceae Family /</subfield><subfield code="c">by Ivan A. Ross.</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1st ed. 2024.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cham :</subfield><subfield code="b">Springer Nature Switzerland :</subfield><subfield code="b">Imprint: Springer,</subfield><subfield code="c">2024.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XXIII, 820 p.) </subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="347" ind1=" " ind2=" "><subfield code="a">text file</subfield><subfield code="b">PDF</subfield><subfield code="2">rda</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Ch01: The History of Brassicaceae Plants -- Ch-02: The Bioactive Components of Brassicaceae -- Ch-03: Chemical Constituents of Brassicaceae -- Ch-04: Nutrigenomics and Metabolomics of the Bioactive Compounds -- ch-05: The Anticarcinogenic Properties of Brassica Vegetables -- ch-06: Neurodegenerative Diseases -- ch-07: Epigenetic Modulation by Isothiocyanates -- ch-08: Breast Cancer -- ch-09: Brain Cancer -- ch-10: Cancer of the Gastrointestinal Tract -- ch-11: Cancer of the Urinary Bladder -- ch-12: Prostate Cancer -- Ch13: Brassica Vegetables and Hypothyroidism -- ch14: Brassicaceae and Viral Diseases -- ch15:Melatonin in Plants and Animals.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">For centuries, research has been conducted on the therapeutics of Brassicaceae plants and their health-promoting effects. Cato the Elder (234-149 BCE) documented their properties in his work De agri cultura and recommended using cabbage to compress wounds, swelling, burns, and bone dislocations. For arthritis, he recommended chopped raw cabbage mixed with coriander and cured cabbage mixed with vinegar and honey. In a groundbreaking discovery in the 1990s, scientists at Johns Hopkins University isolated sulforaphane from broccoli, revealing its potent anticancer properties. This naturally occurring compound has proven highly effective, safe, and tolerable and holds immense promise as a chemoprevention agent. It has the potential to combat various cancers, including breast, prostate, gastrointestinal, melanoma, lung, brain, and bladder. But its potential does not stop there. It also shows promise in treating cardiovascular and neurodegenerative diseases and diabetes, offering hope for those affected. The cancer-protecting properties of Brassica plants are mediated through compounds that induce a variety of physiological processes, including antioxidant action, detoxifying enzymes, inducing apoptosis, and cell cycle regulation. Glucosinolate breakdown products can affect several stages of cancer development, including the inhibition of activation enzymes (phase I) and the induction of detoxification enzymes (phase II). Isothiocyanates and indole products formed from glucosinolates regulate cancer cell development by regulating target enzymes, controlling apoptosis, inhibiting angiogenesis, metastasis, and the migration of cancer cells, and blocking the cell cycle. Sulforaphane, found in abundance in broccoli sprouts, plays a crucial role in upregulating the transcriptional activity of specific genes and restoring epigenetic alterations. This is particularly significant as it modifies epigenetic pathways by targeting histone deacetylases and DNA methyltransferases. These modifications, in turn, alter gene transcription and expression, particularly in the case of cancers. This intricate process of gene regulation is a fascinating study area, making broccoli sprouts a compelling component of the 'epigenetic diet.' Sulforaphane induces the cytoprotective enzyme NQO1. The inducible expression of NQO1 is regulated principally through the Keap1-Nrf2-ARE signaling pathway. The activation of the Nrf2-Keap1 signaling pathway heralds the beneficial actions of drugs known to affect Nrf2 signaling, such as dimethyl fumarate, an FDA-approved treatment for multiple sclerosis, and bardoxolone methyl for chronic kidney disease. There is optimism that the overall strategies are moving forward. Sulforaphane-rich broccoli sprout extracts provide one avenue toward this end.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Botany.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Alternative medicine.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Pharmacology.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Medicinal chemistry.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Agriculture.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Physiology.</subfield></datafield><datafield tag="650" ind1="1" ind2="4"><subfield code="a">Plant Science.</subfield></datafield><datafield tag="650" ind1="2" ind2="4"><subfield code="a">Complementary and Alternative Medicine.</subfield></datafield><datafield tag="650" ind1="2" ind2="4"><subfield code="a">Pharmacology.</subfield></datafield><datafield tag="650" ind1="2" ind2="4"><subfield code="a">Medicinal Chemistry.</subfield></datafield><datafield tag="650" ind1="2" ind2="4"><subfield code="a">Agriculture.</subfield></datafield><datafield tag="650" ind1="2" ind2="4"><subfield code="a">Physiology.</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">SpringerLink (Online service)</subfield></datafield><datafield tag="773" ind1="0" ind2=" "><subfield code="t">Springer Nature eBook</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Printed edition:</subfield><subfield code="z">9783031636806</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Printed edition:</subfield><subfield code="z">9783031636820</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Printed edition:</subfield><subfield code="z">9783031636837</subfield></datafield><datafield tag="966" ind1="4" ind2="0"><subfield code="l">DE-355</subfield><subfield code="p">ZDB-2-SBL</subfield><subfield code="q">UBG_PDA_SBL</subfield><subfield code="u">https://doi.org/10.1007/978-3-031-63681-3</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SBL</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SXB</subfield></datafield><datafield tag="950" ind1=" " ind2=" "><subfield code="a">Biomedical and Life Sciences (SpringerNature-11642)</subfield></datafield><datafield tag="950" ind1=" " ind2=" "><subfield code="a">Biomedical and Life Sciences (R0) (SpringerNature-43708)</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SBL</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield></record></collection> |
id | ZDB-2-SBL-978-3-031-63681-3 |
illustrated | Not Illustrated |
indexdate | 2025-06-23T13:27:58Z |
institution | BVB |
isbn | 9783031636813 |
language | English |
open_access_boolean | |
owner | DE-355 DE-BY-UBR |
owner_facet | DE-355 DE-BY-UBR |
physical | 1 Online-Ressource (XXIII, 820 p.) |
psigel | ZDB-2-SBL UBG_PDA_SBL ZDB-2-SBL ZDB-2-SXB |
publishDate | 2024 |
publishDateSearch | 2024 |
publishDateSort | 2024 |
publisher | Springer Nature Switzerland : Imprint: Springer, |
record_format | marc |
spelling | Ross, Ivan A. author. aut http://id.loc.gov/vocabulary/relators/aut Plant-Based Therapeutics, Volume 2 [electronic resource] : The Brassicaceae Family / by Ivan A. Ross. 1st ed. 2024. Cham : Springer Nature Switzerland : Imprint: Springer, 2024. 1 Online-Ressource (XXIII, 820 p.) text txt rdacontent computer c rdamedia online resource cr rdacarrier text file PDF rda Ch01: The History of Brassicaceae Plants -- Ch-02: The Bioactive Components of Brassicaceae -- Ch-03: Chemical Constituents of Brassicaceae -- Ch-04: Nutrigenomics and Metabolomics of the Bioactive Compounds -- ch-05: The Anticarcinogenic Properties of Brassica Vegetables -- ch-06: Neurodegenerative Diseases -- ch-07: Epigenetic Modulation by Isothiocyanates -- ch-08: Breast Cancer -- ch-09: Brain Cancer -- ch-10: Cancer of the Gastrointestinal Tract -- ch-11: Cancer of the Urinary Bladder -- ch-12: Prostate Cancer -- Ch13: Brassica Vegetables and Hypothyroidism -- ch14: Brassicaceae and Viral Diseases -- ch15:Melatonin in Plants and Animals. For centuries, research has been conducted on the therapeutics of Brassicaceae plants and their health-promoting effects. Cato the Elder (234-149 BCE) documented their properties in his work De agri cultura and recommended using cabbage to compress wounds, swelling, burns, and bone dislocations. For arthritis, he recommended chopped raw cabbage mixed with coriander and cured cabbage mixed with vinegar and honey. In a groundbreaking discovery in the 1990s, scientists at Johns Hopkins University isolated sulforaphane from broccoli, revealing its potent anticancer properties. This naturally occurring compound has proven highly effective, safe, and tolerable and holds immense promise as a chemoprevention agent. It has the potential to combat various cancers, including breast, prostate, gastrointestinal, melanoma, lung, brain, and bladder. But its potential does not stop there. It also shows promise in treating cardiovascular and neurodegenerative diseases and diabetes, offering hope for those affected. The cancer-protecting properties of Brassica plants are mediated through compounds that induce a variety of physiological processes, including antioxidant action, detoxifying enzymes, inducing apoptosis, and cell cycle regulation. Glucosinolate breakdown products can affect several stages of cancer development, including the inhibition of activation enzymes (phase I) and the induction of detoxification enzymes (phase II). Isothiocyanates and indole products formed from glucosinolates regulate cancer cell development by regulating target enzymes, controlling apoptosis, inhibiting angiogenesis, metastasis, and the migration of cancer cells, and blocking the cell cycle. Sulforaphane, found in abundance in broccoli sprouts, plays a crucial role in upregulating the transcriptional activity of specific genes and restoring epigenetic alterations. This is particularly significant as it modifies epigenetic pathways by targeting histone deacetylases and DNA methyltransferases. These modifications, in turn, alter gene transcription and expression, particularly in the case of cancers. This intricate process of gene regulation is a fascinating study area, making broccoli sprouts a compelling component of the 'epigenetic diet.' Sulforaphane induces the cytoprotective enzyme NQO1. The inducible expression of NQO1 is regulated principally through the Keap1-Nrf2-ARE signaling pathway. The activation of the Nrf2-Keap1 signaling pathway heralds the beneficial actions of drugs known to affect Nrf2 signaling, such as dimethyl fumarate, an FDA-approved treatment for multiple sclerosis, and bardoxolone methyl for chronic kidney disease. There is optimism that the overall strategies are moving forward. Sulforaphane-rich broccoli sprout extracts provide one avenue toward this end. Botany. Alternative medicine. Pharmacology. Medicinal chemistry. Agriculture. Physiology. Plant Science. Complementary and Alternative Medicine. Medicinal Chemistry. SpringerLink (Online service) Springer Nature eBook Printed edition: 9783031636806 Printed edition: 9783031636820 Printed edition: 9783031636837 |
spellingShingle | Ross, Ivan A. Plant-Based Therapeutics, Volume 2 The Brassicaceae Family / Ch01: The History of Brassicaceae Plants -- Ch-02: The Bioactive Components of Brassicaceae -- Ch-03: Chemical Constituents of Brassicaceae -- Ch-04: Nutrigenomics and Metabolomics of the Bioactive Compounds -- ch-05: The Anticarcinogenic Properties of Brassica Vegetables -- ch-06: Neurodegenerative Diseases -- ch-07: Epigenetic Modulation by Isothiocyanates -- ch-08: Breast Cancer -- ch-09: Brain Cancer -- ch-10: Cancer of the Gastrointestinal Tract -- ch-11: Cancer of the Urinary Bladder -- ch-12: Prostate Cancer -- Ch13: Brassica Vegetables and Hypothyroidism -- ch14: Brassicaceae and Viral Diseases -- ch15:Melatonin in Plants and Animals. Botany. Alternative medicine. Pharmacology. Medicinal chemistry. Agriculture. Physiology. Plant Science. Complementary and Alternative Medicine. Medicinal Chemistry. |
title | Plant-Based Therapeutics, Volume 2 The Brassicaceae Family / |
title_auth | Plant-Based Therapeutics, Volume 2 The Brassicaceae Family / |
title_exact_search | Plant-Based Therapeutics, Volume 2 The Brassicaceae Family / |
title_full | Plant-Based Therapeutics, Volume 2 [electronic resource] : The Brassicaceae Family / by Ivan A. Ross. |
title_fullStr | Plant-Based Therapeutics, Volume 2 [electronic resource] : The Brassicaceae Family / by Ivan A. Ross. |
title_full_unstemmed | Plant-Based Therapeutics, Volume 2 [electronic resource] : The Brassicaceae Family / by Ivan A. Ross. |
title_short | Plant-Based Therapeutics, Volume 2 |
title_sort | plant based therapeutics volume 2 the brassicaceae family |
title_sub | The Brassicaceae Family / |
topic | Botany. Alternative medicine. Pharmacology. Medicinal chemistry. Agriculture. Physiology. Plant Science. Complementary and Alternative Medicine. Medicinal Chemistry. |
topic_facet | Botany. Alternative medicine. Pharmacology. Medicinal chemistry. Agriculture. Physiology. Plant Science. Complementary and Alternative Medicine. Medicinal Chemistry. |
work_keys_str_mv | AT rossivana plantbasedtherapeuticsvolume2thebrassicaceaefamily AT springerlinkonlineservice plantbasedtherapeuticsvolume2thebrassicaceaefamily |